PALOXI

This brand name is authorized in Israel

Active ingredients

The drug PALOXI contains one active pharmaceutical ingredient (API):

1 Palonosetron
UNII 23310D4I19 - PALONOSETRON HYDROCHLORIDE

Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor.

Read about Palonosetron

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A04AA05 Palonosetron A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AA Serotonin (5HT3) antagonists
Discover more medicines within A04AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4974, 8884

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈